Hematopoietic and Lymphoid Neoplasms
📧 Sign up to get email alerts when something new happens for Hematopoietic and Lymphoid Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning
This clinical trial update reports the completion of a study evaluating 3D surface scanning for Virtual-CT-based radiation therapy treatment…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients [NA]
This clinical trial update outlines research on understanding challenges, behavioral patterns, and preferences toward participation in clini…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Collection of Outcomes Data for Pregnant Patients With Cancer
This terminated clinical trial focused on collecting outcomes data for pregnant patients with cancer, involving hematopoietic/lymphoid neopl…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
AIDS Malignancy Consortium is recruiting for a study to collect blood and tissue samples from participants with HIV/AIDS-related cancers to …
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy [Phase 3]
A Phase 3 trial evaluated apixaban to prevent recurrent cancer-related venous thromboembolism in patients who completed initial anticoagulat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating bortezomib with chemotherapy in lymphoid malignancies undergoing stem cell transplantation; results posted…